Literature DB >> 27529019

Neoadjuvant chemotherapy in Albinos with locally advanced skin cancer at a Blantyre Hospital: - Case Series.

I A Chidothe1, L Masamba1.   

Abstract

UNLABELLED: Albinism in Africa remains a public health concern with increasing numbers of advanced skin cancer in this population at presentation. There are challenges with availability of Radiotherapy (RT) units in Africa which is an important modality for controlling loco-regional disease alone or in combination with surgery. Proposed chemotherapy regimens have not been well validated through Randomized Controlled Trials thus posing difficulties for standard of care for units that do not have access to functional RT facilities. Malawi is one such country without radiotherapy. CASE
SUMMARY: Seven patients with locally advanced skin cancer were seen in the adult oncology unit at Queen Elizabeth Central Hospital in Blantyre (QECH), Malawi between 2010 and 2013. QECH is one of the teaching hospitals in the country. All were subjected to neo-adjuvant chemotherapy. The primary treatment aim was cyto-reduction followed by surgery whilst the secondary outcome was general symptom control. Three patients achieved complete responses of which two underwent resection and a pectoralis major myocutaneous flap. One had a near complete response and three showed partial responses.
CONCLUSION: Neo-adjuvant chemotherapy may be a possible.

Entities:  

Mesh:

Year:  2014        PMID: 27529019      PMCID: PMC4248047     

Source DB:  PubMed          Journal:  Malawi Med J        ISSN: 1995-7262            Impact factor:   0.875


  9 in total

1.  Locally advanced skin cancer in an albino: a treatment dilemma.

Authors:  G Mapurisa; L Masamba
Journal:  Malawi Med J       Date:  2010-12       Impact factor: 0.875

2.  Albinism and skin cancer in Southern Africa.

Authors:  J G Kromberg; D Castle; E M Zwane; T Jenkins
Journal:  Clin Genet       Date:  1989-07       Impact factor: 4.438

3.  Advanced skin cancer in Tanzanian albinos: preliminary observations.

Authors:  G A Alexander; U K Henschke
Journal:  J Natl Med Assoc       Date:  1981-11       Impact factor: 1.798

4.  Skin cancers in albinos in a teaching Hospital in eastern Nigeria - presentation and challenges of care.

Authors:  Kingsley O Opara; Bernard C Jiburum
Journal:  World J Surg Oncol       Date:  2010-08-25       Impact factor: 2.754

5.  Letter: Skin cancer in albinos at the University of Calabar Teaching Hospital, Calabar, Nigeria.

Authors:  M E Asuquo; O O Otei; J Omotoso; E E Bassey
Journal:  Dermatol Online J       Date:  2010-04-15

6.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Authors:  E A Eisenhauer; P Therasse; J Bogaerts; L H Schwartz; D Sargent; R Ford; J Dancey; S Arbuck; S Gwyther; M Mooney; L Rubinstein; L Shankar; L Dodd; R Kaplan; D Lacombe; J Verweij
Journal:  Eur J Cancer       Date:  2009-01       Impact factor: 9.162

7.  Skin cancer in African albinos.

Authors:  A Yakubu; O A Mabogunje
Journal:  Acta Oncol       Date:  1993       Impact factor: 4.089

8.  Skin cancers among Albinos at a University teaching hospital in Northwestern Tanzania: a retrospective review of 64 cases.

Authors:  Joseph B Mabula; Phillipo L Chalya; Mabula D Mchembe; Hyasinta Jaka; Geofrey Giiti; Peter Rambau; Nestory Masalu; Erasmus Kamugisha; Ssentongo Robert; Japhet M Gilyoma
Journal:  BMC Dermatol       Date:  2012-06-08

Review 9.  Histological review of skin cancers in African Albinos: a 10-year retrospective review.

Authors:  Samson Kimaiyo Kiprono; Baraka Michael Chaula; Helmut Beltraminelli
Journal:  BMC Cancer       Date:  2014-03-06       Impact factor: 4.430

  9 in total
  2 in total

1.  Prevalence of Squamous and Basal Cell Carcinomas in African Albino Skin Cancer Lesions: A Systematic Review and Meta-Analysis of Proportion.

Authors:  Nnaemeka T Onyishi; Samuel R Ohayi
Journal:  J Skin Cancer       Date:  2022-08-30

2.  Cancer Pathology Turnaround Time at Queen Elizabeth Central Hospital, the Largest Referral Center in Malawi for Oncology Patients.

Authors:  Leo P L Masamba; Petani E Mtonga; Linda Kalilani Phiri; Brittany L Bychkovsky
Journal:  J Glob Oncol       Date:  2017-04-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.